Evidence map›Paper›PMID 26891996›Full record

ArticleScientific reports2016

Estrogen replacement therapy-induced neuroprotection against brain ischemia-reperfusion injury involves the activation of astrocytes via estrogen receptor β.

Yulong Ma, Hang Guo, Lixia Zhang, Liang Tao, Anqi Yin, Zhaoyu Liu, Yan Li, Hailong Dong, Lize Xiong, Wugang Hou

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yulong MaDepartment of Anesthesiology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Hang GuoDepartment of Anesthesiology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Lixia ZhangFirst Affiliated Hospital to Chinese PLA General Hospital, Beijing 100048, China.
Liang TaoDepartment of Anesthesiology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Anqi YinDepartment of Anesthesiology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Zhaoyu LiuDepartment of Anesthesiology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Yan LiDepartment of Anesthesiology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Hailong DongDepartment of Anesthesiology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Lize XiongDepartment of Anesthesiology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Wugang HouDepartment of Anesthesiology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China.
Air Force Medical University · CNXijing Hospital · CNFirst Affiliated Hospital of Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of ischemic stroke is significantly increased in postmenopausal women. However, the neuroprotective effects of estrogen replacement therapy (ERT) against stroke remain controversial, and the role of astrocytes in ERT has rarely been explored. In this study, we investigated the effects of estrogen and selective estrogen receptor (ER) agonists on astrocytes activation and neuronal apoptosis in mice under conditions of cell culture oxygen and glucose deprivation and reperfusion (OGD-R), and global cerebral ischemia (GCI). We demonstrated that hippocampal astrocytes primarily express ERβ. In astrocytes, 2.5-20 nM 17β-estradiol (E2) or 10 nM DPN (ERβ agonist) not 10 nM PPT (ERα agonist), significantly increased GFAP expression. And 10 nM E2, DPN or E2+MPP (ERα antagonist), but not PPT or E2+PHTPP (ERβ antagonist), significantly reduced neuronal apoptosis following the subjection of astrocyte and neuronal cocultures to OGD-R. We also found that either 50 μg/kg E2 or 8 mg/kg DPN replacement (3 weeks) significantly increased GFAP expression and reduced GCI-induced neuronal apoptosis in hippocampal CA1 region of ovariectomized mice. These results indicate that estrogen-induced neuroprotection against ischemia-reperfusion injury involves activation of astrocytes via ERβ. Thus, the discovery and design of astrocyte-selective ERβ modulators may offer a new strategy for ERT of ischemic stroke.

Indexed as

AnimalsApoptosisAstrocytesBrain IschemiaCaspase 3Disease Models, AnimalEstrogen Receptor alphaEstrogen Receptor betaEstrogen Replacement TherapyEstrogensFemaleGlial Fibrillary Acidic ProteinHippocampusMiceNeuronsNeuroprotective AgentsCaspase 3Estrogen Receptor alphaEstrogen Receptor betaEstrogensGlial Fibrillary Acidic ProteinNeuroprotective Agents

Identifiers

PMID26891996
PMCPMC4759820
OpenAlexW2415332733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.